Graft-Versus-Host Disease
Researchers from Fred Hutchinson Cancer Research Center describe findings in graft-versus-host disease
Published in Cancer Weekly, August 12th, 2008
Fresh data on graft-versus-host disease are presented in the report 'Late effects of chronic graft-versus-host disease.' According to recent research from the United States, "Hematopoietic-cell transplantation (HCT) has become applicable to a broader range of ages and underlying diagnoses through advances in the utilization of alternative donors and stem-cell sources, reduced-intensity preparative regimens, and improved supportive care. The reduction in early transplant-related mortality means that more survivors will potentially develop chronic graft-versus-host disease (cGVHD) and associated late effects."
"Recipients of HCT are at risk for late end-organ dysfunction...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-08-12)
More Articles from Cancer Weekly
- Weber Shandwick Worldwide
Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds - Brain Cancer
Drugs Commonly Used for Erectile Dysfunction Allowed More Chemotherapy to Reach Brain Tumors in Laboratory Animal Study - Cancer Gene Therapy
New cancer gene therapy research from F. Wang and co-researchers described - Cancer Gene Therapy
Research from Chiba University yields new findings on cancer gene therapy - Cancer Gene Therapy
Studies from Nankai University have provided new data on cancer gene therapy - Cancer Gene Therapy
Studies from S. Loiselmeyer et al further understanding of cancer gene therapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
